W W Grainger Inc vs Tempus AI — how do they compare? W W Grainger Inc trades at $1,300.82 (market cap $61.11B), while Tempus AI trades at $55.55 (market cap $9.93B). The key difference: W W Grainger Inc is far larger — about 6.2× Tempus AI's market cap, and W W Grainger Inc pays a 0.77% dividend while Tempus AI pays none. Which is the better fit depends on your goals.
| GWW | TEM | |
|---|---|---|
Market Cap | $61.11B | $9.93B |
Sector | Technology | Broad Market / Factor |
52-Week High | $1.40K | $103.25 |
52-Week Low | $918.18 | $41.55 |
Enterprise Value | $63.32B | $10.56B |
Dividend Yield | 0.77% | — |
Signals from Pluang's Aura AI — not financial advice
GWW trades at $1,277.55, down 0.39% on the day, amid a bearish technical signal. The stock has shown strong fundamental performance with Q2 2026 EPS beating estimates at $12.01 and revenue growth to $5.0 billion, leading to a raised full-year outlook. Analyst consensus is a Buy with a $1,310 price target, though technical indicators suggest near-term pressure with support at $1,270 and resistance at $1,290.
The outlook for GWW is positive based on earnings momentum and margin expansion, but risks include macroeconomic sensitivity and competitive pressures. The stock's high P/E of 33.07 indicates premium valuation, requiring sustained growth to justify current levels. Institutional sentiment remains cautious with a Hold-heavy rating distribution.
Tempus AI (TEM) trades at $52.05, up 12.86% in 24 hours, reflecting strong momentum after Q2 2026 earnings beat revenue estimates and raised 2026 sales guidance. The stock is technically bullish with moving averages supporting upside, while fundamentals show revenue growth to $1.4 billion in 2026 but persistent net losses. Recent news highlights expansion through the Personalis acquisition and AI-driven precision medicine advancements.
Outlook: Growth prospects are robust with AI adoption in healthcare and strategic deals, but high valuation ratios and negative profitability pose risks. Analysts are bullish with a $61.57 consensus target, though cash burn and competitive pressures require monitoring for sustained investor confidence.
Trailing returns across standard periods
Latest headlines on both assets
Grainger is a leading broad-line distributor of maintenance, repair, and operating (MRO) products. It serves millions of customers worldwide through an integrated network of branches and digital platforms.
Read more on GWW →Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →